Xegen
Private Company
Funding information not available
Overview
Xegen is a Paris-based bioinformatics CRO that leverages its expertise in NGS data analysis and proprietary software to support R&D in complex genomic areas for research institutions and biotech companies. The company has established credibility through strategic collaborations with notable French research institutes and holds certifications like ISO 13485 and CIR accreditation. Its business model is focused on providing high-value, customized data analysis services and software, positioning it as a specialized partner in the growing field of computational biology.
Technology Platform
Custom bioinformatics pipeline development and proprietary software (e.g., Polypheme® for immunogenetics) for NGS/RNA-seq data analysis, supported by an ISO 13485-certified Quality Management System.
Opportunities
Risk Factors
Competitive Landscape
Xegen competes with other specialized bioinformatics CROs, academic core facilities, and the in-house teams of large pharma. Its differentiation lies in its deep customization, certified quality processes, and niche expertise in areas like HLA immunogenetics and microbial genomics. Larger, generalist CROs with bioinformatics divisions pose a competitive threat for broader service contracts.